Recently, Massa et al. (2015), have published that in HHT patients, the population of blood circulating CD34+ endothelial cells is increased, irrespective of the disease variant (HHT1 or HHT2). This evidence concerns the gene CD34 and hereditary hemorrhagic telangiectasia.